Redeye notes that Sivers’ Q1 2025 report was strong, with another quarter of record net sales reachi...
Redeye returns with positive estimate adjustments following GomSpace’s trading update that beat our ...
Fiskars announced yesterday evening that the CEO, Nathalie Ahlström will step down with imminent eff...
Redeye retains its Base Case and makes minor forecast adjustments following the full Q1 report, with...
Strong Q1 sales of SEK 57m, +49% y-o-y '25e-'27e sales and EBIT up 5-6% and 9%, respectively Growth ...
STENOCARE A/S (STENOCARE or the “Company”) published on May 8th the Company’s Q1-report for 2025.
Encouraging results, even if it was low season We raise our EBITA estimates 2-3% on '25e-'27e Svensk...
AcuCort (”AcuCort” eller ”Bolaget”) har publicerat Bolagets delårsrapport för det första kvartalet 2...
Redeye provides an initial take following the release of Corline’s Q1 2025 report.
Redeye's provides its initial take on Xbrane's Q1 report which confirmed a stronger than anticipated...
Redeye provides a brief comment on Paxman’s announcement to complete the offer for Dignitana.
Redeye notes that Paxman completes the offer to Dignitana.
Redeye states that the Q1 report came in above our estimates on both sales and adjusted EBITDA, with...
Redeye comments on Transtema’s Q1 report, showing strong organic growth in Sweden but a relatively s...
Sales +9% and EBIT +14% vs. ABGSCe Expect cons. to raise '25e-'27e sales by ~3-4% USD/SEK movements ...
Sales 2% higher than expected; 24% y-o-y FX adjusted But higher investments increased lead to miss o...
Redeye comments on Nekkar’s Q1 report that missed our expectations, mainly driven by a lower revenue...
Redeye comments on Truecaller’s Q1 2025 report, which was somewhat softer than expected.
Redeye noted that BeammWave's Q1 2025 report significantly exceeded expectations, primarily due to r...
Redeye updates on Invisio following weaker than expected Q1-results.
